Carl Zeiss Meditec Posts Slight Revenue Growth
Currency effects and regional variations in business burden results
Carl Zeiss Meditec AG closed financial year 2013/2014 with a slight growth in revenue from € 906 million to € 909 million, in spite of unfavorable currency trends. Adjusted for currency effects, growth amounted to 3.0 percent. Earnings before taxes totaled € 120.7 million, which corresponds to an EBIT margin of 13.3 percent. The company achieved substantial increases in case-number-dependent revenue which accounted for as much as 28 percent of revenue in the financial year just ended.
The Carl Zeiss Meditec Group achieved a balanced distribution of revenue across its three regions of the world in financial year 2013/2014. The development of its business units continued to be varied, however. A negative valuation result from currency hedging transactions reduced earnings per share, which reached € 0.92. The distribution of a regular dividend of 40 cents shall be proposed to the Annual General Meeting; the dividend ratio would therefore be slightly higher than the previous year, at around 43%.
Dr. Ludwin Monz, President and CEO of Carl Zeiss Meditec AG, gave his take on the figures: "In spite of adverse currency trends and to some extent difficult markets, we have achieved a satisfactory result. The rise in case-number-dependent revenue is a very positive development. Once again, we achieved a significant increase in this area, to 28 percent."
Other news from the department business & finance
